Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT-980 in RHO-adRP
NCT07408232Phase 2Recruiting
- Sponsor
- Octant
- Start
- Mar 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OCT-980 in retinitis pigmentosa (RP), sponsored by Octant. Started Mar 2026; status: recruiting.
02
Drugs
OCT-980
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT07408232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07408232.